Uncoupling of activation of Fc receptors via a mutant IgG1 Fc domain shows a direct role for complement receptors in antibody-dependent tumor killing.
References
Lee, C.H. et al. Nat. Immunol. 18, 889–898 (2017).
Cartron, G. et al. Blood 99, 754–758 (2002).
Weng, W.K. & Levy, R. J. Clin. Oncol. 21, 3940–3947 (2003).
Meyer, S., Leusen, J.H. & Boross, P. MAbs 6, 1133–1144 (2014).
Biburger, M., Lux, A. & Nimmerjahn, F. Adv. Immunol. 124, 67–94 (2014).
Bournazos, S. & Ravetch, J.V. Immunol. Rev. 268, 88–103 (2015).
DiLillo, D.J. & Ravetch, J.V. Cancer Immunol. Res. 3, 704–713 (2015).
Weiner, G.J. Nat. Rev. Cancer 15, 361–370 (2015).
Hezareh, M., Hessell, A.J., Jensen, R.C., van de Winkel, J.G. & Parren, P.W. J. Virol. 75, 12161–12168 (2001).
Idusogie, E.E. et al. J. Immunol. 166, 2571–2575 (2001).
Bruhns, P. & Jönsson, F. Immunol. Rev. 268, 25–51 (2015).
Bajic, G., Degn, S.E., Thiel, S. & Andersen, G.R. EMBO J. 34, 2735–2757 (2015).
Teachey, D.T. et al. Blood 121, 5154–5157 (2013).
Winkler, U. et al. Blood 94, 2217–2224 (1999).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
van der Poel, C., Carroll, M. Untangling Fc and complement receptors to kill tumors. Nat Immunol 18, 874–875 (2017). https://doi.org/10.1038/ni.3797
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3797
- Springer Nature America, Inc.